| Literature DB >> 27095510 |
Anne Y R Kühlmann1, Jonathan R G Etnel2, Jolien W Roos-Hesselink3, Johannes Jeekel4, Ad J J C Bogers2, Johanna J M Takkenberg5.
Abstract
BACKGROUND: Adverse effects, treatment resistance and high costs associated with pharmacological treatment of hypertension have led to growing interest in non-pharmacological complementary therapies such as music interventions. This meta-analysis aims to provide an overview of reported evidence on the efficacy of music interventions in the treatment of hypertension.Entities:
Keywords: Global health care delivery; Hypertension; Meta-analysis; Music intervention; Systemic review
Mesh:
Year: 2016 PMID: 27095510 PMCID: PMC4837643 DOI: 10.1186/s12872-016-0244-0
Source DB: PubMed Journal: BMC Cardiovasc Disord ISSN: 1471-2261 Impact factor: 2.298
Fig. 1Flowchart of literature search and study selection
Overview of publications, all RCTs
| First author | Year | Study arm |
| Age (years) | M % | History of HT % | Anti-HT drugs % | Follow-up (days) | Timing of intervention | Description |
|---|---|---|---|---|---|---|---|---|---|---|
| Bekiroglu [ | 2013 | M | 30 | 75.5 (7.1) | 57 | 100 | 90 | 28 | 1×/day | Turkish Classical |
| C | 30 | 78.2 (6.1) | 57 | 100 | 90 | Resting Period | ||||
| Modesti [ | 2010 | M | 26 | 58.0 (−) | 62 | 100 | 77 | 180 | 1×/day | Classical, Celtic, Indian |
| C | 29 | 58.0 (−) | 55 | 100 | 73 | Music Guided Slow-Breathing (Buteyko-Pranayama) | ||||
| Zanini [ | 2009 | M | 23 | 66.5 (9.1) | 30 | 100 | 100 | 84 | 1×/week | Recreation, Improvisation, Composition, Listening of musicb |
| C | 22 | 67.2 (9.6) | 55 | 100 | 100 | No Intervention (Standard Medical Therapy) | ||||
| Chan [ | 2009 | M | 23 | >60 | 44 | 61 | - | 28 | 1×/day-1×/week | Western-, Chinese-, Asian Classical, Western Jazz |
| C | 24 | >60 | 46 | 67 | - | Resting Period | ||||
| Tang [ | 2009 | M | 22 | 85.0 (5.0) | 18 | 59 | 32 | 84 | 3×/week | Mozart |
| C | 19 | 86.0 (6.0) | 11 | 68 | 42 | Audio Relaxation Program Training (Revitalizer II) | ||||
| Altena [ | 2009 | M | 15 | 59.0 (11.7) | 53 | 100 | 100 | 63 | Preferably daily | Slow Music |
| C | 15 | 60.0 (11.0) | 47 | 100 | 100 | Resperate® (Device Guided Breathing Exercises) | ||||
| Pandic [ | 2008 | M | 22 | 66.5 (8.3) | 18 | 100 | 77 | 112 | 3×/week | Relaxing Music |
| C | 31 | 70.4 (8.7) | 32 | 100 | 77 | Resperate® (Device Guided Breathing Exercises) | ||||
| Logtenberg [ | 2007 | M | 15 | 59.0 (11.7) | 67 | 100 | 100 | 56 | 1×/day | Various Kinds of Music |
| C | 15 | 62.7 (6.0) | 20 | 100 | 100 | Resperate® (Device Guided Breathing Exercises) | ||||
| Schein [ | 2001 | M | 29 | 56.5 (8.0) | 39 | 100 | 76 | 56 | 1×/day | Quiet Synthesized Music with Non-Identifiable Rhythm |
| C | 32 | 57.8 (9.4) | 56 | 100 | 91 | Breathe with Interactive Music (BIM) Device | ||||
| Grossman [ | 2001 | M | 15 | 50.0 (4.0) | 67 | 100 | 53 | 56 | 1×/day | Quiet Synthesized Music with Non-Identifiable Rhythm |
| C | 18 | 52.0 (12.0) | 72 | 100 | 56 | Breathe with Interactive Music (BIM) Device |
RCT randomized controlled trial, M music arm, C control arm, HT hypertension
aStudy with Resting period/No intervention as control group
bThis study used music therapy whereas the others used recorded music interventions
Pooled outcome measures of music intervention arms of included studies
| First author | SBP baseline (mmHg) | SBP end (mmHg) | DBP baseline (mmHg) | DBP end (mmHg) | Mean SBP reduction (mmHg) | Mean DBP reduction (mmHg) |
|---|---|---|---|---|---|---|
| Bekiroglu [ | 128.2 (6.7) | 115.2 (5.3) | 77.5a(−) | 70.0a(−) | 13.0a(−) | 7.5a(−) |
| Modesti [ | 131.0 (13.0) | 129.7a(−) | 79.0 (9.1) | 77.6a(−) | 1.3 (7.0) | 1.4 (5.4) |
| Zanini [ | 149.7 (6.4) | 133.8 (13.4) | 89.1 (9.1) | 80.1 (10.6) | 15.9a(−) | 9.0a(−) |
| Chan [ | 143.8 (23.8) | 130.1 (28.1) | 73.1 (11.5) | 67.7 (14.0) | 17.3a(−) | 5.4a(−) |
| Tang [ | 145.0 (19.0) | 139.0 (17.0) | 74.0 (10.0) | 71.0 (10.0) | 6.0a(−) | 3.0a(−) |
| Altena [ | 133.9 (15.7) | 131.0 (11.5) | 78.4 (11.1) | 75.0 (13.2) | 2.9 (6.1) | 3.4 (9.2) |
| Pandic [ | 151.8 (15.7) | 135.1 (10.6) | 82.7 (9.8) | 78.7 (7.7) | 16.0a(−) | 4.1a(−) |
| Logtenberg [ | 150.4 (8.2) | 138.2 (10.3) | 87.0 (8.3) | 81.5 (8.3) | 12.2 (9.4) | 5.5 (7.5) |
| Schein [ | 154.7 (8.5) | 143.4a(−) | 93.4 (7.1) | 87.8a(−) | 11.3 (12.8) | 5.6 (6.2) |
| Grossman [ | 155.0 (11.0) | 152.1 (12.1) | 94.0 (6.0) | 92.5 (9.1) | 2.9 (12.1) | 1.5 (9.1) |
| R-E model | 144.4 | 134.3 | 83.6 | 78.2 | 6.0 | 3.5 |
| (95 % CI) | (136.7–152.1) | (124.0–144.5) | (78.2–88.9) | (72.6–83.8) | (1.5–10.4) | (1.4–5.7) |
| Heterogeneity |
|
|
|
|
| X2
|
| I2 = 97 % | I2 = 97 % | I2 = 95 % | I2 = 91 % | I2 = 84 % | I2 = 56 % |
Data expressed as “mean (SD)”, “mean (95 % CI)” or proportions
R-E model random-effects model, SBP systolic blood pressure, DBP diastolic blood pressure
aExcluded from analysis due to unavailable measures of dispersion
Pooled outcome measures of the studies with both intervention and control arms
| SBP baseline (mmHg) | SBP end (mmHg) | DBP baseline (mmHg) | DBP end (mmHg) | ||
|---|---|---|---|---|---|
| Intervention | Bekiroglu [ | 128.2 (6.7) | 115.2 (5.3) | 77.5a(−) | 70.0a(−) |
| Zanini [ | 149.7 (6.4) | 133.8 (13.4) | 89.1 (9.1) | 80.1 (10.6) | |
| Chan [ | 143.8 (23.8) | 130.1 (28.1) | 73.1 (11.5) | 67.7 (14.0) | |
| Heterogeneity |
|
|
|
| |
| I2 = 99 % | I2 = 96 % | I2 = 96 % | I2 = 91 % | ||
| R-E model | 140.4 | 126.0 | 81.2 | 74.1 | |
| (95 % CI) | (123.7–157.2) | (111.5–140.5) | (65.5–96.9) | (61.9–86.2) | |
| F-E model | 138.2 | 117.5 | 82.9 | 75.6 | |
| (95 % CI) | (136.5–140.0) | (115.7–119.2) | (80.0–85.9) | (72.1–79.0) | |
| Control | Bekiroglu [ | 121.2 (5.9) | 114.7 (6.0) | 80.0a(−) | 70.0a(−) |
| Zanini [ | 145.4 (5.6) | 141.0 (19.8) | 86.9 (11.3) | 83.9 (12.4) | |
| Chan [ | 143.7 (22.1) | 140.9 (26.4) | 72.7 (12.8) | 71.4 (13.6) | |
| Heterogeneity |
|
|
|
| |
| I2 = 99 % | I2 = 96 % | I2 = 94 % | I2 = 91 % | ||
| R-E model | 136.6 | 131.8 | 79.8 | 77.7 | |
| (95 % CI) | (117.6–155.6) | (110.9–152.7) | (65.9–93.8) | (65.4–89.9) | |
| F-E model | 132.5 | 117.3 | 80.4 | 78.0 | |
| (95 % CI) | (130.9–134.0) | (115.2–119.3) | (76.9–83.9) | (74.2–81.7) |
Data expressed as “mean (SD)”, “mean (95 % CI)” or proportions
R-E model random-effects model, F-E model fixed-effect model, SBP systolic blood pressure, DBP diastolic blood pressure
aExcluded from analysis due to unavailable measures of dispersion
Fig. 2Mean change in systolic blood pressure in different study-arms in the three comparative studies. SBP = systolic blood pressure
Fig. 3Mean change in diastolic blood pressure in different study-arms in the three comparative studies. DBP = diastolic blood pressure